Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Asthma D001249 52 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Brain Injuries D001930 4 associated lipids
Bronchial Diseases D001982 3 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Burns, Inhalation D002059 4 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dyslexia D004410 3 associated lipids
Ear Diseases D004427 7 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Epilepsy D004827 35 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Gastritis D005756 27 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Gliosis D005911 6 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Injuries D006335 6 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemolysis D006461 131 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Mazer BD et al. Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes. 1998 J. Allergy Clin. Immunol. pmid:9723666
Beyer AJ et al. PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis. 1998 Am. J. Physiol. pmid:9724257
Rougier F and Denizot Y Platelet-activating factor and the growth of fibroblasts. 1998 Mol. Carcinog. pmid:9726813
Matsumoto K et al. Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. 1998 Eur. Respir. J. pmid:9727790
Ibe BO et al. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb. 1998 J. Appl. Physiol. pmid:9729586
Qu XW et al. Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. 1998 J. Physiol. (Lond.) pmid:9729632
Ueno M et al. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen. 1998 Pharmacology pmid:9730778
Burke-Gaffney A and Hellewell PG A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9730868
M'Rabet L et al. Activation of the small GTPase rap1 in human neutrophils. 1998 Blood pmid:9731072
Cheryk LA et al. Alterations in blood platelet morphology during aggregate formation in the Asian elephant (Elephas maximus). 1998 J. Zoo Wildl. Med. pmid:9732033
Liu L et al. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. 1998 J. Immunol. pmid:9743372
Kruse-Elliott KT et al. Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor. 1998 Shock pmid:9744648
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Rocha MF et al. Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta. 1998 Infect. Immun. pmid:9746596
Endo S et al. Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment. 1998 Childs Nerv Syst pmid:9753399
Heath MF et al. Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists. 1998 Equine Vet. J. pmid:9758098
El-Shazly A et al. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate. 1998 Int. Arch. Allergy Immunol. pmid:9758889
Matsumoto K et al. Altered expression of CD11b and CD62L after cross-linking of CD45 isoforms on human eosinophils. 1998 Int. Arch. Allergy Immunol. pmid:9758894
El-Shazly A et al. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. 1998 Int. Arch. Allergy Immunol. pmid:9758899
Kinn JW and Bache RJ Effect of platelet activation on coronary collateral blood flow. 1998 Circulation pmid:9760298
Tamm M et al. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9761763
Spoelstra FM et al. Effect of theophylline on CD11b and L-selectin expression and density of eosinophils and neutrophils in vitro. 1998 Eur. Respir. J. pmid:9762784
Kabasakal C et al. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. 1998 Jul-Sep Turk. J. Pediatr. pmid:9763906
Marriott I et al. Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages: evidence for calcium-dependent and independent-signalling pathways. 1998 J. Cell. Physiol. pmid:9766520
Bozza PT et al. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. 1998 J. Leukoc. Biol. pmid:9766638
Kern H et al. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. 1998 Biochim. Biophys. Acta pmid:9767093
Le Blanc K et al. Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. 1998 Thromb. Res. pmid:9772010
Abu-Zidan FM Hope or hype for lexipafant? 1998 Nature pmid:9774090
Perez S et al. Inhibition by the anti-mitotic drug doxorubicin of platelet-activating-factor-induced late eosinophil accumulation in rats. 1998 Eur. J. Pharmacol. pmid:9774255
Teather LA et al. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory. 1998 Neurobiol Learn Mem pmid:9774526
Suzuki T et al. 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists. 1998 Chem. Pharm. Bull. pmid:9775441
Shah BH et al. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. 1998 Biochem. Pharmacol. pmid:9776305
Serebruany VL et al. Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction. 1998 Cardiology pmid:9778550
Akisü M et al. The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury. 1998 Acta Med. Okayama pmid:9781268
SariahmetoÄŸlu M et al. Effects of WEB 2086 on the protective role of preconditioning against arrhythmias in rats. 1998 Pharmacol. Res. pmid:9782066
Carlson SA and Jones BD Inhibition of Salmonella typhimurium invasion by host cell expression of secreted bacterial invasion proteins. 1998 Infect. Immun. pmid:9784535
Akisü M et al. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. 1998 Biol. Neonate pmid:9784635
Momose T et al. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression. 1998 Int. Arch. Allergy Immunol. pmid:9784658
O'Neill C Role of autocrine mediators in the regulation of embryo viability: lessons from animal models. 1998 J. Assist. Reprod. Genet. pmid:9785192
Kaneshiro ES et al. Characterizations of Pneumocystis carinii and rat lung lipids: glyceryl ethers and fatty alcohols. 1998 J. Lipid Res. pmid:9788237
Ohno Y et al. Effects of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig. 1998 Ann. Otol. Rhinol. Laryngol. pmid:9794619
Pestonjamasp VK and Burstein SH Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. 1998 Biochim. Biophys. Acta pmid:9795237
Hofbauer B et al. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. 1998 Gastroenterology pmid:9797380
Templeton AG et al. Effects of S-salbutamol on human isolated bronchus. 1998 Pulm Pharmacol Ther pmid:9802957
Choi IH et al. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. 1998 J. Exp. Med. pmid:9802970
Izzo AA et al. Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. 1998 Trends Pharmacol. Sci. pmid:9803830
Aida Y et al. Effects of chroman derivatives on platelet aggregation induced by some aggregating agents in rabbits. 1998 Clin. Exp. Pharmacol. Physiol. pmid:9807668
Montrucchio G et al. Potential angiogenic role of platelet-activating factor in human breast cancer. 1998 Am. J. Pathol. pmid:9811351
Denizot Y et al. Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells. 1998 Cytokine pmid:9811531
Song SQ and Hu YM Effects of tetrandrine, Fura 2-AM, and Bay k 8644 on platelet-activating factor release from rat peritoneal macrophages stimulated by lipopolysaccharides. 1996 Zhongguo Yao Li Xue Bao pmid:9812743
Nakos G et al. Bronchoalveolar lavage alterations in pulmonary embolism. 1998 Am. J. Respir. Crit. Care Med. pmid:9817700
Kwiterovich PO The antiatherogenic role of high-density lipoprotein cholesterol. 1998 Am. J. Cardiol. pmid:9819099
Siafaka-Kapadai A et al. Effects of suramin on human platelet aggregation and Ca2+ mobilization induced by thrombin and other agonists. 1998 Life Sci. pmid:9820121
Malpuech-Brugère C et al. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. 1998 Life Sci. pmid:9820125
Takafuji S et al. Release of granule proteins from human eosinophils stimulated with mast-cell mediators. 1998 Allergy pmid:9821474
Akisü M et al. Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: is it an additional marker of perinatal asphyxia? 1998 Acta Paediatr Jpn pmid:9821700
Pulliam L et al. Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. 1998 J. Neurosci. Res. pmid:9822163
Kilgore KS et al. Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor. 1998 Inflammation pmid:9824773
Smalley DM et al. Platelet activating factor (PAF) increases leukocyte adhesion but does not alter vessel diameter in the rat mesenteric microcirculation. 1998 Microvasc. Res. pmid:9828165
Itabe H Oxidized phospholipids as a new landmark in atherosclerosis. 1998 Jul-Aug Prog. Lipid Res. pmid:9829125
Ohashi H et al. Sulochrin inhibits eosinophil activation and chemotaxis. 1998 Inflamm. Res. pmid:9831326
Auchampach JA et al. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function. 1998 Basic Res. Cardiol. pmid:9833148
Stack WA et al. Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial. The Platelet Activating Factor Antagonist Study Group in Ulcerative Colitis. 1998 Gastroenterology pmid:9834260
Dupuis F et al. Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors. 1998 Mediators Inflamm. pmid:9836496
Travers J et al. Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783. 1998 Arch. Dermatol. Res. pmid:9836508
Ottlakán A Role of platelet-activating factor in glucose uptake and utilization of different tissues. 1998 Eur Surg Res pmid:9838231
Takada Y et al. Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. 1998 Transplant. Proc. pmid:9838621
Fukunaga K et al. Successful liver transplantation from non-heart-beating donors by blockade of endothelin and PAE. 1998 Transplant. Proc. pmid:9838664
Witko-Sarsat V et al. Priming of blood neutrophils in children with cystic fibrosis: correlation between functional and phenotypic expression of opsonin receptors before and after platelet-activating factor priming. 1999 J. Infect. Dis. pmid:9841834
Kimura S et al. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum. 1998 Immunol. Invest. pmid:9845423
Koyama S et al. Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines. 1998 Am. J. Pathol. pmid:9846978
Masubuchi T et al. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. 1998 Am. J. Pathol. pmid:9846980
Jean WC et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. 1998 Neurosurgery pmid:9848853
Swain SD et al. Platelet-activating factor induces a concentration-dependent spectrum of functional responses in bovine neutrophils. 1998 J. Leukoc. Biol. pmid:9850166
Steil AA et al. Modulation by lipid mediators of immune complex-induced lung inflammation in mice. 1998 Eur. J. Pharmacol. pmid:9851546
Xiao YQ et al. Pharmacological analysis of protein kinases responsible for chemotaxis of rat peritoneal neutrophils. 1998 Eur. J. Pharmacol. pmid:9851586
Reverdiau-Moalic P et al. Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathway. 1998 J. Lab. Clin. Med. pmid:9851744
Reiner O and Sapir T Abnormal cortical development; towards elucidation of the LIS1 gene product function (review). 1998 Int. J. Mol. Med. pmid:9852306
Gardner JP and Zhang L Glucocorticoid modulation of Ca2+ homeostasis in human B lymphoblasts. 1999 J. Physiol. (Lond.) pmid:9852321
Stamatiou P et al. 5-oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in Brown Norway rats. 1998 J. Clin. Invest. pmid:9854052
Sharif NA et al. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. 1998 Invest. Ophthalmol. Vis. Sci. pmid:9856766
Chihara J et al. Inhibitory effect of ibudilast (KC-404) on the expression of the beta2 integrin family on an eosinophilic cell line (EoL-1). 1998 Ann. Allergy Asthma Immunol. pmid:9860039
Egesten A and Malm J Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C. 1998 Allergy pmid:9860239
Nagai H et al. Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice. 1999 J. Pharmacol. Exp. Ther. pmid:9862751
Jeanneton O et al. Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig. 1998 Gut pmid:9863481
Hammer C et al. Xenogeneic rejection mechanisms shown by intravital microscopy. 1998 Transplant. Proc. pmid:9865335
Pesce L et al. Effect of Fenoterol on PAF-induced lung edema in isolated and perfused rabbit lungs. 1998 Respir Physiol pmid:9865589
Kaminskaia GO et al. [Oxidative metabolic changes, antioxidantion, and platelet activation rat phagocytes during development of experimental specific tuberculous changes]. 1998 Probl Tuberk pmid:9866402
Venugopalan CS et al. Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease. 1998 Vet. Res. Commun. pmid:9868763
pmid:9870780
Powell WS et al. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. 1999 Am. J. Respir. Cell Mol. Biol. pmid:9870930
Chen JZ et al. A 3D-QSAR study on ginkgolides and their analogues with comparative molecular field analysis. 1998 Bioorg. Med. Chem. Lett. pmid:9871752
Dutra PM et al. A novel ecto-phosphatase activity of Herpetomonas muscarum muscarum inhibited by platelet-activating factor. 1998 Biochem. Biophys. Res. Commun. pmid:9875238
Huh H et al. PAF antagonistic activity of 2-hydroxy-3-methoxybenzoic acid glucose ester from Gentiana scabra. 1998 Arch. Pharm. Res. pmid:9875472
Zhang J et al. Strategies of myocardial protection for operation in chronic model of cyanotic heart disease. 1998 Ann. Thorac. Surg. pmid:9875743
Dhainaut JF et al. Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. 1998 Crit. Care Med. pmid:9875905
Kawasaki Y et al. Specific detections of the early process of the glycation reaction by fructose and glucose in diabetic rat lens. 1998 FEBS Lett. pmid:9877177
Todoroki H et al. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils. 1998 J. Surg. Res. pmid:9878306
Nakano T et al. Roxythromycin reinforces epithelial defence function in rabbit trachea. 1998 Acta Otolaryngol Suppl pmid:9879427
Chang FR et al. Two new 7-dehydroaporphine alkaloids and antiplatelet action aporphines from the leaves of Annona purpurea. 1998 Phytochemistry pmid:9883592